Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAD | P27708 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21381783 | 1.00 | CAD (0.41) | CADL3MBTL1CPB2MGAMGAA | |
| Hydrochloric Acid SCHEMBL23522225 | 0.98 | CAD (0.40) | CADL3MBTL1CPB2MGAMGAA | |
| Hydrochloric Acid SCHEMBL30161768 | 0.98 | CAD (0.40) | CADL3MBTL1CPB2MGAMGAA | |
| SCHEMBL28761538 | 0.93 | SMN1; SMN2 (0.44) | CADL3MBTL1CPB2MGAMGAA | |
| SCHEMBL10523453 | 0.92 | CAD (0.39) | CADL3MBTL1CPB2MGAMGAA | |
| SCHEMBL21082352 | 0.89 | CAD (0.35) | CADL3MBTL1CPB2MGAMGAA | |
| SCHEMBL4991214 | 0.89 | CAD (0.35) | CADL3MBTL1CPB2MGAMGAA | |
| SCHEMBL17385231 | 0.89 | CPB2 (0.46) | CADL3MBTL1CPB2MGAMGAA | |
| SCHEMBL10523433 | 0.87 | TSHR (0.40) | CADL3MBTL1CPB2KMT2APOLB | |
| SCHEMBL8768440 | 0.86 | CAD (0.40) | CADL3MBTL1CPB2MGAMGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20240390364-A1 | Novel Pyridine Compositions and their use in methods for preventing or treating diseases, disorders and conditions | REID CHRISTOPHER BRIAN (US) | 2024-11-28 | — | — | US | claimed |
| US-20090209740-A1 | COMPOSITION FOR PREPARATION OF RADIOACTIVE PHARMACEUTICAL FOR DIAGNOSIS OF REGIONAL CEREBRAL BLOOD FLOW | FUJIFILM RI PHARMA CO., LTD (JP) | 2009-08-20 | — | — | US | claimed |
| EP-2000154-A9 | COMPOSITION FOR PREPARATION OF RADIOACTIVE PHARMACEUTICAL FOR DIAGNOSIS OF REGIONAL CEREBRAL BLOOD FLOW | Fujifilm RI Pharma Co., Ltd. (JP) | 2009-03-18 | — | — | EP | claimed |
| EP-2000154-A2 | COMPOSITION FOR PREPARATION OF RADIOACTIVE PHARMACEUTICAL FOR DIAGNOSIS OF REGIONAL CEREBRAL BLOOD FLOW | Fujifilm RI Pharma Co., Ltd. (JP) | 2008-12-10 | — | — | EP | claimed |
| US-5280015-A | 2-substituted adenosines and 2-substituted adenosine 5'-carboxamides | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-01-18 | — | — | US | claimed |
| EP-4731194-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP Technologies, Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12514525-B2 | Radiopharmaceutical dispensing systems | JUBILANT DRAXIMAGE INC. (CA) | 2026-01-06 | — | — | US | disclosed |
| WO-2025264260-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP TECHNOLOGIES, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| US-20250367121-A1 | DOSAGE FORMS COMPRISING ACTIVE PHARMACEUTICAL INGREDIENTS | AXSOME THERAPEUTICS INC (US) | 2025-12-04 | — | — | US | disclosed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | disclosed |
| WO-2024263560-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP TECHNOLOGIES, INC. (US) | 2024-12-26 | — | — | WO | disclosed |
| US-20240390364-A1 | Novel Pyridine Compositions and their use in methods for preventing or treating diseases, disorders and conditions | REID CHRISTOPHER BRIAN (US) | 2024-11-28 | — | — | US | disclosed |
| WO-2007111020-A1 | COMPOSITION FOR PREPARATION OF RADIOACTIVE PHARMACEUTICAL FOR DIAGNOSIS OF REGIONAL CEREBRAL BLOOD FLOW | FUJIFILM RI PHARMA CO., LTD. (JP) | 2007-10-04 | — | — | WO | disclosed |
| US-6403054-B1 | MEDICAL DIAGNOSIS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-06-11 | — | — | US | disclosed |
| EP-0984791-A1 | TERNARY LIGAND COMPLEXES USEFUL AS RADIOPHARMACEUTICALS | Du Pont Pharmaceuticals Company (US) | 2000-03-15 | — | — | EP | disclosed |
| US-5986074-A | CHELATE COMPOUNDS AS IMAGING AGENTS AND KITS | EMORY UNIVERSITY (US) | 1999-11-16 | — | — | US | disclosed |
| US-5955053-A | TECHNETIUM OR RHENIUM CHELATES WITH LIGANDS SUCH AS DITHIOUREA, CYSTEINYLETHYLENE OR THIOACETAMIDETHIOUREA FOR IMAGES | EMORY UNIVERSITY (US) | 1999-09-21 | — | — | US | disclosed |
| WO-1998053858-A1 | TERNARY LIGAND COMPLEXES USEFUL AS RADIOPHARMACEUTICALS | DU PONT PHARMACEUTICALS COMPANY (US) | 1998-12-03 | — | — | WO | disclosed |
| US-5280015-A | 2-substituted adenosines and 2-substituted adenosine 5'-carboxamides | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-01-18 | — | — | US | disclosed |